Cargando…

Effect of therapies-mediated modulation of telomere and/or telomerase on cancer cells radiosensitivity

Cancer is one of the leading causes of death in the world. Many strategies of cancer treatment such as radiotherapy which plays a key role in cancer treatment are developed and used nowadays. However, the side effects post-cancer radiotherapy and cancer radioresistance are two major causes of the li...

Descripción completa

Detalles Bibliográficos
Autores principales: Assani, Ganiou, Xiong, Yudi, Zhou, Fuxiang, Zhou, Yunfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201854/
https://www.ncbi.nlm.nih.gov/pubmed/30405890
http://dx.doi.org/10.18632/oncotarget.26150
_version_ 1783365584012967936
author Assani, Ganiou
Xiong, Yudi
Zhou, Fuxiang
Zhou, Yunfeng
author_facet Assani, Ganiou
Xiong, Yudi
Zhou, Fuxiang
Zhou, Yunfeng
author_sort Assani, Ganiou
collection PubMed
description Cancer is one of the leading causes of death in the world. Many strategies of cancer treatment such as radiotherapy which plays a key role in cancer treatment are developed and used nowadays. However, the side effects post-cancer radiotherapy and cancer radioresistance are two major causes of the limitation of cancer radiotherapy effectiveness in the cancer patients. Moreover, reduction of the limitation of cancer radiotherapy effectiveness by reducing the side effects post-cancer radiotherapy and cancer radioresistance is the aim of several radiotherapy-oncologic teams. Otherwise, Telomere and telomerase are two cells components which play an important role in cancer initiation, cancer progression and cancer therapy resistance such as radiotherapy resistance. For resolving the problems of the limitation of cancer radiotherapy effectiveness especially the cancer radio-resistance problems, the radio-gene-therapy strategy which is the use of gene-therapy via modulation of gene expression combined with radiotherapy was developed and used as a new strategy to treat the patients with cancer. In this review, we summarized the information concerning the implication of telomere and telomerase modulation in cancer radiosensitivity.
format Online
Article
Text
id pubmed-6201854
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-62018542018-11-07 Effect of therapies-mediated modulation of telomere and/or telomerase on cancer cells radiosensitivity Assani, Ganiou Xiong, Yudi Zhou, Fuxiang Zhou, Yunfeng Oncotarget Review Cancer is one of the leading causes of death in the world. Many strategies of cancer treatment such as radiotherapy which plays a key role in cancer treatment are developed and used nowadays. However, the side effects post-cancer radiotherapy and cancer radioresistance are two major causes of the limitation of cancer radiotherapy effectiveness in the cancer patients. Moreover, reduction of the limitation of cancer radiotherapy effectiveness by reducing the side effects post-cancer radiotherapy and cancer radioresistance is the aim of several radiotherapy-oncologic teams. Otherwise, Telomere and telomerase are two cells components which play an important role in cancer initiation, cancer progression and cancer therapy resistance such as radiotherapy resistance. For resolving the problems of the limitation of cancer radiotherapy effectiveness especially the cancer radio-resistance problems, the radio-gene-therapy strategy which is the use of gene-therapy via modulation of gene expression combined with radiotherapy was developed and used as a new strategy to treat the patients with cancer. In this review, we summarized the information concerning the implication of telomere and telomerase modulation in cancer radiosensitivity. Impact Journals LLC 2018-10-09 /pmc/articles/PMC6201854/ /pubmed/30405890 http://dx.doi.org/10.18632/oncotarget.26150 Text en Copyright: © 2018 Assani et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Review
Assani, Ganiou
Xiong, Yudi
Zhou, Fuxiang
Zhou, Yunfeng
Effect of therapies-mediated modulation of telomere and/or telomerase on cancer cells radiosensitivity
title Effect of therapies-mediated modulation of telomere and/or telomerase on cancer cells radiosensitivity
title_full Effect of therapies-mediated modulation of telomere and/or telomerase on cancer cells radiosensitivity
title_fullStr Effect of therapies-mediated modulation of telomere and/or telomerase on cancer cells radiosensitivity
title_full_unstemmed Effect of therapies-mediated modulation of telomere and/or telomerase on cancer cells radiosensitivity
title_short Effect of therapies-mediated modulation of telomere and/or telomerase on cancer cells radiosensitivity
title_sort effect of therapies-mediated modulation of telomere and/or telomerase on cancer cells radiosensitivity
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201854/
https://www.ncbi.nlm.nih.gov/pubmed/30405890
http://dx.doi.org/10.18632/oncotarget.26150
work_keys_str_mv AT assaniganiou effectoftherapiesmediatedmodulationoftelomereandortelomeraseoncancercellsradiosensitivity
AT xiongyudi effectoftherapiesmediatedmodulationoftelomereandortelomeraseoncancercellsradiosensitivity
AT zhoufuxiang effectoftherapiesmediatedmodulationoftelomereandortelomeraseoncancercellsradiosensitivity
AT zhouyunfeng effectoftherapiesmediatedmodulationoftelomereandortelomeraseoncancercellsradiosensitivity